Pharmaceutical industry – Page 18
-
BusinessCancer and rare diseases dominated 2019 drug approvals
More streamlined review processes and changing R&D priorities have contributed to sustained increase in new medicines
-
BusinessResearchers call for stricter rules on drug-like medical devices
More oversight is needed over products in the grey area between medical device and medication
-
OpinionStartup EQRx claims it can revolutionise drug discovery
If it can deliver reasonable drugs at knock-down prices, will providers be convinced?
-
OpinionReviewing performance reviews
Assessing the value of researchers’ work is hard, but there are some easy ideas to avoid
-
BusinessRevived Alzheimer’s antibody met with guarded optimism
Biogen’s aducanumab offers the possibility to slow disease progress, but regulators will likely want more convincing evidence
-
ResearchCompact pharmaceutical factory manufactures drugs on demand
Plant with modular design would occupy about half the area of a squash court
-
-
BusinessTissue scaffolds from resin inks
4D Medicine’s biodegradable polymer inks can be 3D-printed into useful biomedical applications
-
OpinionWhen should employees share profits from inventions?
Glucose monitor inventor wins £2m payout from Unilever after claiming his work provided ’outstanding benefit’
-
BusinessPharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better
-
BusinessChemicals industry roundup 2019
Focus turns to sustainability amid rising economic pressures and political uncertainty
-
PodcastOxycodone and hydrocodone
Frances Addison examines how our quest to control and manage pain has led to a modern medical crisis, as opioids oxycodone and hydrocodone are among the most abused prescription medications in the US
-
-
ArticlePharma and healthcare meets data and digitalisation
UK-based company Life Science Integrates exists to facilitate collaboration between digital, pharma and life sciences industries – helping form partnerships that revolutionise healthcare
-
ArticleCultivating innovation in the UK’s life science industry
Scientific and digital collaboration is key to maintaining the UK’s esteemed status in global life sciences and pharma circles. CPI exists to facilitate and underpin those vital relationships
-
ArticleArtificial intelligence: on the cusp of a digital revolution
AI is transforming the pharma industry and its drug discovery pipeline
-
ArticleIon mobility spectrometry: the future of pharma analysis
Ion mobility spectrometry is transforming the field of biomolecule research, with Waters technology at the forefront of this vital analytical innovation
-
-
OpinionWill computers ever discover drugs from scratch?
With enough understanding and computing power, it should be possible, but will it happen?
-
BusinessFormer Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo